140 related articles for article (PubMed ID: 19227896)
1. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].
Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896
[TBL] [Abstract][Full Text] [Related]
2. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
Kim KH; Song JS; Park CW; Ki CS; Heo K
Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
[TBL] [Abstract][Full Text] [Related]
3. A clinical and neurophysiological motor signature of Unverricht-Lundborg disease.
Hainque E; Blancher A; Mesnage V; Rivaud-Pechoux S; Bertrand A; Dupont S; Navarro V; Roze E; Gourfinkel-An I; Apartis E
Rev Neurol (Paris); 2018; 174(1-2):56-65. PubMed ID: 28688606
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of cortical hyperexcitability in Japanese Unverricht-Lundborg disease.
Kobayashi K; Hitomi T; Matsumoto R; Kondo T; Kawamata J; Matsuhashi M; Hashimoto S; Ikeda H; Koide Y; Inoue Y; Takahashi R; Ikeda A
Seizure; 2014 Oct; 23(9):746-50. PubMed ID: 25023721
[TBL] [Abstract][Full Text] [Related]
5. Clinical picture of EPM1-Unverricht-Lundborg disease.
Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
[TBL] [Abstract][Full Text] [Related]
6. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
Santoshkumar B; Turnbull J; Minassian BA
Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
[TBL] [Abstract][Full Text] [Related]
7. Major intra-familial variability in Unverricht-Lundborg disease.
Nasri A; Zidi S; Kacem I; Mrabet S; Ben Djebara M; Gargouri A; Leguern E; Gouider R
Epileptic Disord; 2022 Feb; 24(1):163-170. PubMed ID: 34787084
[TBL] [Abstract][Full Text] [Related]
8. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.
Chew NK; Mir P; Edwards MJ; Cordivari C; Martino D; Schneider SA; Kim HT; Quinn NP; Bhatia KP
Mov Disord; 2008 Jan; 23(1):107-13. PubMed ID: 17994572
[TBL] [Abstract][Full Text] [Related]
9. [Unverricht-Lundborg disease (PME1)].
Genton P
Rev Neurol (Paris); 2006 Sep; 162(8-9):819-26. PubMed ID: 17028542
[TBL] [Abstract][Full Text] [Related]
10. Unverricht-Lundborg disease in a five-generation Arab family: instability of dodecamer repeats.
Mazarib A; Xiong L; Neufeld MY; Birnbaum M; Korczyn AD; Pandolfo M; Berkovic SF
Neurology; 2001 Sep; 57(6):1050-4. PubMed ID: 11571333
[TBL] [Abstract][Full Text] [Related]
11. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
[TBL] [Abstract][Full Text] [Related]
12. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease.
Canafoglia L; Ciano C; Panzica F; Scaioli V; Zucca C; Agazzi P; Visani E; Avanzini G; Franceschetti S
Neurology; 2004 Dec; 63(12):2309-15. PubMed ID: 15623692
[TBL] [Abstract][Full Text] [Related]
13. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
Genton P; Gelisse P; Crespel A
Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
[TBL] [Abstract][Full Text] [Related]
14. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
[TBL] [Abstract][Full Text] [Related]
15. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
[TBL] [Abstract][Full Text] [Related]
16. FOunder effect in patients with Unverricht-Lundborg disease on reunion island.
Moulard B; Darcel F; Mignard D; Jeanpierre M; Genton P; Cartault F; Yaouanq J; Roubertie A; Biraben A; Buresi C; Malafosse A
Epilepsia; 2003 Oct; 44(10):1357-60. PubMed ID: 14510831
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study.
Bosak M; Sułek A; Łukasik M; Żak A; Słowik A; Lasek-Bal A
Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease.
Muccioli L; Farolfi A; Pondrelli F; Matteo E; Ferri L; Licchetta L; Alvisi L; Tinuper P; Bisulli F
Epilepsy Behav Rep; 2022; 19():100551. PubMed ID: 35620304
[TBL] [Abstract][Full Text] [Related]
19. Unverricht-Lundborg disease with cystatin B gene abnormalities.
Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
[TBL] [Abstract][Full Text] [Related]
20. Unverricht-Lundborg disease: Clinical course and seizure management based on the experience of polish centers.
Lasek-Bal A; Lukasik M; Żak A; Sulek A; Bosak M
Seizure; 2019 Jul; 69():87-91. PubMed ID: 30999254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
